Revenue and Profitability - Revenues for the year ended December 31, 2024 increased by 19,997 compared to 1,215 or 7% to 18,595 for the year ended December 31, 2023[137] - Gross profit for the year ended December 31, 2024 was 17,531 in 2023, with gross profit margin decreasing to 90.8% from 92.7%[138] - Net loss for the year ended December 31, 2024 was (0.05) per share, an improvement from a net loss of (0.10) per share in 2023[141] - Adjusted EBITDA for the year ended December 31, 2024 was 377 in 2023, reflecting operational improvements[150] Operating Expenses and Cash Flow - Operating expenses decreased by 19,334 for the year ended December 31, 2024, with research and development expenses decreasing by (2,694) for the year ended December 31, 2024, compared to 2,895[143] Financial Position - Cash and cash equivalents as of December 31, 2024 were 20,933 and stockholders' equity of 4,666[157] - The company has approximately 10,900 expiring between 2035 and 2037[151] - The company anticipates that available cash and expected cash from operations will be sufficient to meet working capital and capital expenditure requirements for at least the next 12 months[146] Investment Activities - The primary objectives of the company's investment activities are capital preservation, liquidity fulfillment, and fiduciary control of cash and investments[157] - The company does not expect a hypothetical 100 basis point change in interest rates to materially affect the fair market value of its investment portfolio[157] - The company has never entered into off-balance sheet financing arrangements or established special purpose entities[156] Regulatory and Accounting Updates - The FASB issued ASU 2024-03, requiring disaggregated disclosures for certain expenses, effective for annual reporting periods beginning after December 15, 2026[155]
Intellicheck(IDN) - 2024 Q4 - Annual Report